Journal of tissue viability · 2026
Kinesiophobia in Crohn's disease: A matched case-control study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Escudero-Prados Juan Manuel, Cortés-Rodríguez Antonio, Losa-Iglesias Marta Elena, Gómez-Salgado Juan, Becerro-de-Bengoa-Vallejo Ricardo, Saavedra-García Miguel Ángel, López-López Daniel, Jiménez-Cebrián Ana María
Аннотация
BACKGROUND: Crohn's disease (CD) is a long-term inflammatory condition and a chronic immune-mediated inflammatory disorder characterized by recurrent gastrointestinal symptoms and substantial physical and psychological burden. However, evidence regarding kinesiophobia in patients with CD remains scarce.
OBJECTIVES: To compare kinesiophobia levels between patients with CD and age-, sex-, and body mass index-matched healthy controls using the Spanish short version of the Tampa Scale of Kinesiophobia Spanish Version (TSK-11SV).
MATERIAL AND METHODS: A matched case-control study was conducted including 108 participants (54 patients with CD and 54 healthy controls). Demographic and anthropometric variables were collected, and all participants completed the TSK-11SV questionnaire. Group differences in continuous variables were analyzed using appropriate inferential statistics after assessment of data distribution. Kinesiophobia severity categories were compared using Contingency tables and measures of association. Effect sizes were calculated to improve clinical interpretation of the findings.
RESULTS: Patients with Crohn's disease presented significantly higher TSK-11SV scores than healthy controls (27.35 ± 6.19 vs. 23.39 ± 5.33 points, respectively). The mean difference was 3.96 points (p < 0.001), corresponding to a moderate effect size (Cohen's dz = 0.69). Moderate-to-extreme kinesiophobia was identified in 70.4% of patients with CD compared with 40.7% of healthy controls (p = 0.015). Extreme kinesiophobia was observed exclusively in the CD group.
CONCLUSIONS: Individuals with CD exhibit significantly greater fear of movement than healthy controls. These findings suggest that kinesiophobia may constitute an important psychological barrier to physical activity in CD and should be routinely considered during multidisciplinary disease management. Early identification of patients with elevated kinesiophobia may facilitate the implementation of individualized exercise-based interventions aimed at improving long-term physical and psychological outcomes.
OBJECTIVES: To compare kinesiophobia levels between patients with CD and age-, sex-, and body mass index-matched healthy controls using the Spanish short version of the Tampa Scale of Kinesiophobia Spanish Version (TSK-11SV).
MATERIAL AND METHODS: A matched case-control study was conducted including 108 participants (54 patients with CD and 54 healthy controls). Demographic and anthropometric variables were collected, and all participants completed the TSK-11SV questionnaire. Group differences in continuous variables were analyzed using appropriate inferential statistics after assessment of data distribution. Kinesiophobia severity categories were compared using Contingency tables and measures of association. Effect sizes were calculated to improve clinical interpretation of the findings.
RESULTS: Patients with Crohn's disease presented significantly higher TSK-11SV scores than healthy controls (27.35 ± 6.19 vs. 23.39 ± 5.33 points, respectively). The mean difference was 3.96 points (p < 0.001), corresponding to a moderate effect size (Cohen's dz = 0.69). Moderate-to-extreme kinesiophobia was identified in 70.4% of patients with CD compared with 40.7% of healthy controls (p = 0.015). Extreme kinesiophobia was observed exclusively in the CD group.
CONCLUSIONS: Individuals with CD exhibit significantly greater fear of movement than healthy controls. These findings suggest that kinesiophobia may constitute an important psychological barrier to physical activity in CD and should be routinely considered during multidisciplinary disease management. Early identification of patients with elevated kinesiophobia may facilitate the implementation of individualized exercise-based interventions aimed at improving long-term physical and psychological outcomes.